Revvity (NYSE:RVTY) Hits New 1-Year High – Here’s Why

Shares of Revvity Inc. (NYSE:RVTY) reached a new 52-week high during trading on Wednesday. The stock traded as high as $168.66 and last traded at $168.11, with a volume of 417,463 shares trading hands. The stock had previously closed at $161.86.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on RVTY. Wall Street Zen cut shares of Revvity from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. William Blair began coverage on Revvity in a report on Monday, October 5th. They issued an “outperform” rating on the stock. KeyCorp increased their price objective on Revvity from $125.00 to $165.00 and gave the company an “overweight” rating in a research report on Friday, September 4th. UBS Group began coverage on Revvity in a research note on Wednesday, September 9th. They set a “neutral” rating and a $140.00 price objective for the company. Finally, Zacks Research upgraded Revvity from a “strong sell” rating to a “hold” rating in a report on Tuesday, August 4th. Five research analysts have rated the stock with a Buy rating and thirteen have assigned a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $124.43.

Revvity Trading Up 0.2%

The company has a market cap of $18.49 billion, a PE ratio of 30.90, a PEG ratio of 3.01 and a beta of 1.06. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.50 and a current ratio of 1.80. The company has a 50 day simple moving average of $143.88 and a two-hundred day simple moving average of $111.88.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Tuesday, August 4th. The company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.21 by $0.20. The firm had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The company’s revenue for the quarter was down 1.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.18 EPS. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. Sell-side analysts forecast that Revvity Inc. will post 5.36 EPS for the current year.

Insider Buying and Selling at Revvity

In related news, insider Tajinder Vohra sold 7,330 shares of the stock in a transaction on Wednesday, September 16th. The stock was sold at an average price of $140.88, for a total transaction of $1,032,650.40. Following the completion of the sale, the insider directly owned 6,635 shares in the company, valued at approximately $934,738.80. This trade represents a 52.49% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Maxwell Krakowiak sold 1,631 shares of Revvity stock in a transaction on Monday, September 21st. The shares were sold at an average price of $144.53, for a total value of $235,728.43. Following the sale, the insider directly owned 14,781 shares of the company’s stock, valued at approximately $2,136,297.93. The trade was a 9.94% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 9,045 shares of company stock valued at $1,281,439. 0.85% of the stock is owned by corporate insiders.

Institutional Trading of Revvity

Large investors have recently modified their holdings of the company. Public Employees Retirement System of Ohio acquired a new position in shares of Revvity in the second quarter valued at $3,845,000. The Manufacturers Life Insurance Company grew its position in Revvity by 5.8% in the second quarter. The Manufacturers Life Insurance Company now owns 368,938 shares of the company’s stock valued at $41,048,000 after acquiring an additional 20,278 shares during the period. Wellington Management Group LLP grew its position in Revvity by 10,653.8% in the second quarter. Wellington Management Group LLP now owns 865,575 shares of the company’s stock valued at $96,304,000 after acquiring an additional 857,526 shares during the period. Tocqueville Asset Management L.P. bought a new stake in Revvity in the second quarter valued at $4,791,000. Finally, State Street Corp raised its stake in Revvity by 0.8% during the second quarter. State Street Corp now owns 4,342,739 shares of the company’s stock worth $483,173,000 after acquiring an additional 32,426 shares in the last quarter. 86.65% of the stock is owned by institutional investors.

Revvity Company Profile

Revvity, Inc provides technology, products and services for the life sciences and diagnostics markets. The company supports pharmaceutical and biotechnology research, clinical laboratories and other healthcare organizations with tools used in drug discovery, biological research, disease detection and laboratory testing.

Its offerings include laboratory instruments, reagents, consumables, software and workflow solutions. Key areas include genomics, proteomics, cellular analysis, imaging, screening, automation and reproductive health, as well as newborn screening and other diagnostic applications.